Description of invasive aspergillosis in Mexican patients with chronic granulomatous disease.

Authors

Tiareth Cova-Guzmán, Deborah Palacios Reyes, Carla M Román-Montes, Marco Antonio Yamazaki-Nakashimada, Aidé Tamara Staines Boone, Luis Silva-Goytia, María de la Luz García-Cruz, Héctor Gómez-Tello, Uriel Pérez-Blanco, Nancy Jiménez-Polvo, Estefany Mamani Velasquez, Nideshda Ramírez Uribe, Isabel Medina Vera, Sara Espinosa Padilla, Lizbeth Blancas-Galicia

Published in

Journal of human immunity. Volume 1. Issue 3. Pages e20250010. Sep 01, 2025. Epub Jul 18, 2025.

Abstract

In chronic granulomatous disease (CGD), Aspergillus is the most common cause of invasive fungal infections and accounts for a high percentage of mortality. We recruited 45 patients of CGD with invasive aspergillosis (IA) events. The median age between the first CGD manifestation and first aspergillosis event was 65 mo. Mortality rate was 57.7% for proven aspergillosis events, 23.1% for probable events, and 19.2% for possible events (p = 0.038). Aspergillus fumigatus was the most common species. Comparing mortality with this cutoff point, 36% of those receiving <75 days of antifungal treatment died compared with 16.7% of those receiving >75 days (p = 0.05). 26 (58%) of the 45 patients died, out of which 18 (69%) had IA. Overall survival of the 45 patients was 80.8% at 64 mo. The high mortality rate of IA in CGD patients could be reduced by early suspicion, initiating correct antifungal treatment over a long period, and considering the performance of hematopoietic stem cell transplantation.

PMID:
42169760
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.